|
IAC Express 2010 |
| Issue number 880: August 2, 2010 |
|
|
Please click here to subscribe to IAC Express
as well as other FREE IAC periodicals. |
|
Contents
of this Issue
Select a title to jump to the article. |
- CDC's
2010 recommendations for prevention and control of
seasonal influenza published as an MMWR Early Release
- MMWR publishes CDC's recommendations for use of yellow
fever vaccine
- MMWR reports on influenza activity in the United States
during the 2009-10 influenza season
- MMWR reports on regional H1N1 influenza vaccination
campaign in Skokie, IL
- IAC's Video of the Week focuses on autism research
- "CDC
Features" educates the public about various
immunization-related topics
- FDA
approves 4 influenza vaccines for the 2010-11 season
- Campaign plans to vaccinate almost 8 million Afghani
children against polio
- IAC updates "Management of Chronic Hepatitis B in Adults"
- CDC website posts presentation slide sets from the June
ACIP meeting
- WHO publishes the June 2010 meeting report of the Global
Advisory Committee on Vaccine Safety
- Reminder: Vaccine Education Center to hold symposium in
Philadelphia on September 25
-
Minnesota immunization conference set for October 15
|
| |
| Abbreviations |
|
|
AAFP, American Academy of Family Physicians; AAP,
American Academy of Pediatrics; ACIP, Advisory Committee on Immunization
Practices; AMA, American Medical Association; CDC, Centers for Disease
Control and Prevention; FDA, Food and Drug Administration; IAC, Immunization
Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NCIRD,
National Center for Immunization and Respiratory Diseases; NIVS, National
Influenza Vaccine Summit; VIS, Vaccine Information Statement; VPD,
vaccine-preventable disease; WHO, World Health Organization. |
| |
|
Issue 880: August 2, 2010 |
|
|
|
1. |
CDC's 2010 recommendations for prevention and control of seasonal influenza
published as an MMWR Early Release
On July 29, CDC published "Prevention and Control
of
Influenza with Vaccines: Recommendations of the Advisory
Committee on Immunization Practices (ACIP), 2010" as an MMWR
Early Release. The Summary section is reprinted below.
This report updates the 2009 recommendations by CDC's
Advisory Committee on Immunization Practices (ACIP)
regarding the use of influenza vaccine for the prevention
and control of influenza (CDC. Prevention and control of
influenza: recommendations of the Advisory Committee on
Immunization Practices [ACIP]. MMWR 2009;58[No. RR-8] and
CDC. Use of influenza A (H1N1) 2009 monovalent vaccine--recommendations of the Advisory Committee on Immunization
Practices [ACIP], 2009. MMWR 2009;58:[No. RR-10]). The 2010
influenza recommendations include new and updated
information. Highlights of the 2010 recommendations include
(1) a recommendation that annual vaccination be administered
to all persons aged >=6 months for the 2010-11 influenza
season; (2) a recommendation that children aged 6 months-8
years whose vaccination status is unknown or who have never
received seasonal influenza vaccine before (or who received
seasonal vaccine for the first time in 2009-10 but received
only 1 dose in their first year of vaccination) as well as
children who did not receive at least 1 dose of an influenza
A (H1N1) 2009 monovalent vaccine regardless of previous
influenza vaccine history should receive 2 doses of a 2010-11 seasonal influenza vaccine (minimum interval: 4 weeks)
during the 2010-11 season; (3) a recommendation that
vaccines containing the 2010-11 trivalent vaccine virus
strains A/California/7/2009 (H1N1)-like (the same strain as
was used for 2009 H1N1 monovalent vaccines), A/Perth/16/2009
(H3N2)-like, and B/Brisbane/60/2008-like antigens be used;
(4) information about Fluzone High-Dose, a newly approved
vaccine for persons aged >=65 years; and (5) information
about other standard-dose newly approved influenza vaccines
and previously approved vaccines with expanded age
indications. Vaccination efforts should begin as soon as the
2010-11 seasonal influenza vaccine is available and continue
through the influenza season. These recommendations also
include a summary of safety data for U.S.-licensed influenza
vaccines. These recommendations and other information are
available at CDC's influenza website
(http://www.cdc.gov/flu); any updates or supplements that
might be required during the 2010-11 influenza season also
will be available at this website. Recommendations for
influenza diagnosis and antiviral use will be published
before the start of the 2010-11 influenza season.
Vaccination and healthcare providers should be alert to
announcements of recommendation updates and should check the
CDC influenza website periodically for additional
information.
To access "Prevention and Control of Influenza with
Vaccines: Recommendations of the Advisory Committee on
Immunization Practices (ACIP), 2010," go to:
http://www.cdc.gov/mmwr/pdf/rr/rr59e0729.pdf
To access all final ACIP recommendations, go to:
http://www.immunize.org/acip IAC's ACIP web section allows
visitors to sort documents by date, vaccine, and topic.
Bookmark this link for easy access to all provisional and
final ACIP recommendations.
Back to top |
| |
|
|
2. |
MMWR publishes CDC's recommendations for use of yellow fever vaccine
CDC published "Yellow Fever Vaccine:
Recommendations of the
Advisory Committee on Immunization Practices (ACIP)" in a
July 30 MMWR Recommendations and Reports. The Summary
section is reprinted below.
This report updates CDC's recommendations for using yellow
fever (YF) vaccine (CDC. Yellow fever vaccine:
recommendations of the Advisory Committee on Immunizations
Practices: MMWR 2002;51 [No. RR-17]). Since the previous YF
vaccine recommendations were published in 2002, new or
additional information has become available on the
epidemiology of YF, safety profile of the vaccine, and
health regulations related to the vaccine. This report
summarizes the current epidemiology of YF, describes
immunogenicity and safety data for the YF vaccine, and
provides recommendations for the use of YF vaccine among
travelers and laboratory workers.
YF is a vectorborne disease resulting from the transmission
of yellow fever virus (YFV) to a human from the bite of an
infected mosquito. It is endemic to sub-Saharan Africa and
tropical South America and is estimated to cause 200,000
cases of clinical disease and 30,000 deaths annually.
Infection in humans is capable of producing hemorrhagic
fever and is fatal in 20%-50% of persons with severe
disease. Because no treatment exists for YF disease,
prevention is critical to lower disease risk and mortality.
A traveler's risk for acquiring YFV is determined by
multiple factors, including immunization status, location of
travel, season, duration of exposure, occupational and
recreational activities while traveling, and local rate of
virus transmission at the time of travel.
All travelers to countries in which YF is endemic should be
advised of the risks for contracting the disease and
available methods to prevent it, including use of personal
protective measures and receipt of vaccine. Administration
of YF vaccine is recommended for persons aged >=9 months who
are traveling to or living in areas of South America and
Africa in which a risk exists for YFV transmission. Because
serious adverse events can occur following YF vaccine
administration, healthcare providers should vaccinate only
persons who are at risk for exposure to YFV or who require
proof of vaccination for country entry. To minimize the risk
for serious adverse events, healthcare providers should
observe the contraindications, consider the precautions to
vaccination before administering vaccine, and issue a
medical waiver if indicated.
To access "Yellow Fever Vaccine: Recommendations of the
Advisory Committee on Immunization Practices (ACIP)," go to:
http://www.cdc.gov/mmwr/pdf/rr/rr5907.pdf
Back to top |
| |
|
|
3. |
MMWR reports on influenza
activity in the United States during the 2009-10 influenza season
CDC published "Update: Influenza Activity--United
States,
2009-10 Season" in the July 30 issue of MMWR. The first
paragraph of the Editorial Note is reprinted below.
April 2009 marked the beginning of the 2009 influenza A
(H1N1) pandemic. The reported rates of pediatric
hospitalization and mortality were the highest recorded
using current surveillance systems; however, rates of
hospitalization and death were lower among older persons
compared to rates typically seen during influenza A (H3N2)
predominant seasons. Substantial levels of transmission and
detection of 2009 pandemic H1N1 virus continued from the
spring into summer in contrast with the usual limited and
sporadic occurrence of influenza viruses during summer
months. Outpatient visits for ILI [influenza-like illness]
continued to persist at elevated levels through the summer,
although the levels reported did not exceed baseline levels,
with the exception of 1 week in April, until late summer and
early fall 2009.
To access the full article in web-text (HTML) format, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5929a2.htm
Back to top |
| |
|
|
4. |
MMWR reports on regional H1N1 influenza vaccination campaign in Skokie, IL
CDC published "Regional Influenza A (H1N1) 2009
Monovalent
Vaccination Campaign--Skokie, Illinois, October 16-December
31, 2009" in the July 30 issue of MMWR. The first paragraph
is reprinted below.
On July 29, 2009, the Advisory Committee on Immunization
Practices (ACIP) recommended a phased approach for
administration of influenza A (H1N1) 2009 monovalent
vaccine, with certain high-risk groups in the United States
receiving the first doses. In Illinois, state authorities
gave responsibility for initial vaccine administration to
local health departments and hospitals. This report
describes the vaccination campaign of the Skokie Health
Department (SHD), during October 16-December 31, 2009. The
SHD campaign initially was planned to cover the 67,000
persons residing in Skokie only, but that plan was expanded
on November 4, when, in response to a nationwide vaccine
shortage, the state health director urged local health
departments to vaccinate any person in the ACIP priority
groups regardless of jurisdictional boundaries. SHD, with
the assistance of 1,075 volunteers, either administered or
distributed to medical providers 40,850 H1N1 vaccine doses
during a 9-week period, including 8,904 doses administered
at 52 Skokie schools and daycare facilities, and 12,876
doses at mass vaccination clinics visited by residents of
193 of the 1,313 Illinois municipalities. At the time of the
campaign, widespread illness from 2009 H1N1 in Illinois,
with highly publicized deaths, contributed to a public sense
of urgency about vaccination. Consistent with published
studies, mass clinics in Skokie were an effective means to
vaccinate large populations rapidly. The campaign
highlighted the need for flexible plans, including the
possibility of vaccinating persons who resided well beyond
SHD's jurisdictional borders.
To access the full article in web-text (HTML) format, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5929a3.htm
Back to top |
| |
|
|
5. |
IAC's Video of the Week focuses on autism research
Researchers around the world are working
diligently to find
the cause(s) of autism and treatments for this disease.
IAC encourages IAC Express readers to watch an 8.4-minute
video about current findings in autism research.
According to the Autism Science Foundation, the science is
very clear: vaccines do not cause autism and it's time to
move on from this well-debunked myth and find out what does.
In this week's video, Dr. Jennifer Pinto-Martin, chair of
the 2010 International Meeting for Autism Research, provides
highlights of the most exciting research findings presented
at the meeting.
The video will be available on the home page of IAC's
website through August 8. To access it, go to:
http://www.immunize.org and click on the image under the
words Video of the Week.
Remember to bookmark IAC's home page to view a new video
every Monday. To view an IAC Video of the Week from the
past, go to the video archive at http://www.immunize.org/votw
Back to top |
| |
|
|
6. |
"CDC Features" educates the public about various immunization-related topics
The "CDC Features" web section includes timely
immunization-related information for the public on measles, rabies, and
pregnancy.
To access "Measles--Make Sure Your Child Is Fully
Immunized," go to: http://www.cdc.gov/Features/Measles
To access "Protect Your Family from Rabies," go to:
http://www.cdc.gov/Features/RabiesSafeFamily
To access "Preventing Infections during Pregnancy," go to:
http://www.cdc.gov/Features/Pregnancy
To access an alphabetical index of all "CDC Features," go
to: http://www.cdc.gov/az
Back to top |
| |
|
|
7. |
FDA approves 4 influenza vaccines for the 2010-11 season
FDA has recently published approval information
for 4
influenza vaccines for the 2010-11 influenza season--FluLaval (GlaxoSmithKline), Fluzone and Fluzone High-Dose
(sanofi pasteur), and FluMist (MedImmune).
FLULAVAL
Approval letter:
http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm112845.htm
Package insert:
http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM112904.pdf
FLUZONE AND FLUZONE HIGH-DOSE
Approval letter:
http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm112854.htm
Package insert:
http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM195479.pdf
FLUMIST
Approval letter:
http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094047.htm
Package insert:
http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM123743.pdf
To obtain package inserts for all licensed U.S. vaccines, go
to: http://www.immunize.org/packageinserts
Back to top |
| |
|
|
8. |
Campaign plans to vaccinate almost 8 million Afghani children against polio
Last week, more than 20,000 volunteers and
healthcare
workers in Afghanistan went door-to-door to deliver oral
polio vaccine as part of a 3-day polio eradication effort.
This campaign is just part of a greater effort led by the
Ministry of Public Health with the support of WHO, UNICEF,
and other partners. This coalition hopes to vaccinate 7.7
Afghani million children by the year's end, despite the
impediments of war, population mobility, and violence
against volunteers.
To read more about this inspiring effort, go to:
http://www.un.org/apps/news/story.asp?NewsID=35432&Cr=polio&Cr1=
Back to top |
| |
|
|
9. |
IAC
updates "Management of Chronic Hepatitis B in Adults"
IAC recently updated "Management of Chronic
Hepatitis B in
Adults." This one-page summary of management of people with
chronic hepatitis B virus infection was reviewed by the
author, Brian McMahon, MD. Dr. McMahon is an internal
medicine specialist and medical director of the Liver
Disease and Hepatitis Program at the Alaska Native Tribal
Health Consortium, Anchorage, Alaska.
To access this updated handout, go to:
http://www.immunize.org/catg.d/p2161.pdf
IAC's Handouts for Patients and Staff web section offers
healthcare professionals and the public approximately 250
FREE English-language handouts (many also available in
translation), which we encourage website users to print out,
copy, and distribute widely. To access all of IAC's free
handouts, go to: http://www.immunize.org/handouts
Back to top |
| |
|
|
10. |
CDC website posts presentation slide sets from the June ACIP meeting
The CDC website recently posted the PowerPoint
slide sets presented at the June 23-24 ACIP meeting.
To access the slide sets, go to:
http://www.cdc.gov/vaccines/recs/acip/slides-jun10.htm
Back to top |
| |
|
|
11. |
WHO publishes the June 2010 meeting report of the Global Advisory Committee
on Vaccine Safety
On July 23, the WHO publication Weekly
Epidemiological
Record (WER) published "Global Advisory Committee on Vaccine
Safety [GACVS], 16-17, June 2010." An expert clinical and
scientific advisory body, GACVS deals independently and with
scientific rigor with vaccine safety issues of potential
global importance.
At the June meeting the committee reviewed the safety of
pandemic A (H1N1) influenza vaccines, an apparent increase
in febrile reactions following administration of a seasonal
influenza vaccine in Australia, the finding of DNA from
porcine circoviruses in rotavirus vaccines, the safety of
live attenuated hepatitis A vaccines, the safety profile of
a prequalified meningococcal A conjugate vaccine, and new
data on yellow fever vaccine-related risks.
To access a ready-to-print (PDF) version of the July 23
issue, go to: http://www.who.int/wer/2010/wer8530.pdf
Back to top |
| |
|
|
12. |
Reminder: Vaccine Education Center to hold symposium in Philadelphia on
September 25
The Vaccine Education Center at The Children's
Hospital of
Philadelphia will hold a Vaccine Education Symposium on
September 25.
For more information, download the symposium brochure at
http://www.chop.edu/system/galleries/download/pdfs/articles/cme/vaccine-2010.pdf
To register online, go to:
https://www.chop.edu/professionals/educational-resources/continuing-medical-education/registration.cfm/vaccine-2010
Back to top |
| |
|
|
13. |
Minnesota immunization conference set for October 15
The Minnesota Department of Health's "Got Your
Shots?"
immunization conference will be held at the Grand View Lodge
at Nisswa, MN, on October 15. The conference will provide an
opportunity for public and private partners to explore
ongoing and upcoming issues related to vaccine-preventable
diseases and immunization.
For more information, go to:
http://www.health.state.mn.us/divs/idepc/immunize/conference/index.html
Back to top |
| |
|
|
